Clinical Trial Update: De-escalation of Ustekinumab Therapy in Patients With Crohn's Disease and Ulcerative Colitis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is investigating de-escalation of ustekinumab therapy in Crohn's disease and ulcerative colitis and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Ulcerative Colitis

Drugs mentioned

• Stelara (ustekinumab)

Snippet

Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre | Conditions: Crohn Disease (CD), Ulcerative Colitis (UC) | Phase 4 | Status: RECRUITING